Biofrontera AG buy melinda
Start price
05.03.18
/
50%
€5.95
Target price
09.03.18
€6.40
Performance (%)
8.07%
End price
09.03.18
€6.43
Summary
This prediction ended on 09.03.18 with a price of €6.43. The BUY prediction by melinda finished with a performance of 8.07%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Biofrontera AG | 7.229% | 7.229% | -69.702% | -85.645% |
iShares Core DAX® | 4.015% | 2.971% | 16.492% | 19.144% |
iShares Nasdaq 100 | 2.755% | 0.503% | 40.029% | 50.636% |
iShares Nikkei 225® | -0.826% | -5.057% | 14.566% | 2.379% |
iShares S&P 500 | 2.330% | 0.720% | 30.194% | 44.181% |
According to melinda what are the pros and cons of Biofrontera AG for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Biofrontera AG diskutieren
Biotechnologie und Medizintechnik SecteurRecherche Kalender 11/07 Generalversammlung
Biofrontera: Die Europäische Kommission genehmigt die Verwendung von Ameluz in Kombination mit der photodynamischen Therapie Tageslicht
5. März (Reuters) - Die Biofrontera AG :: PTA-ADHOC: Biofrontera AG: DIE EUROPÄISCHE KOMMISSION GENEHMIGT DEN EINSATZ IN KOMBINATION MIT Ameluz THERAPY Photodynamischen den Tag.
(Zielkurs erreicht)
Stopped prediction by melinda for Biofrontera AG
Biofrontera AG
Start price
Target price
Perf. (%)
€1.60
06.12.21
06.12.21
€2.80
06.12.22
06.12.22
-1.25%
07.12.22
07.12.22
Could be worthwhile Investment >10% per year
Biofrontera AG
Start price
Target price
Perf. (%)
€3.16
17.03.20
17.03.20
€6.00
04.11.21
04.11.21
-25.32%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Biofrontera AG
Start price
Target price
Perf. (%)
€6.29
09.03.18
09.03.18
€8.00
14.03.18
14.03.18
13.99%
14.03.18
14.03.18
Could be worthwhile Investment >10% per year